UroGen Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.

About URGN

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. 

CEO
Elizabeth Barrett
CEOElizabeth Barrett
Employees
235
Employees235
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2004
Founded2004
Employees
235
Employees235

URGN Key Statistics

Market cap
918.81M
Market cap918.81M
Price-Earnings ratio
-5.98
Price-Earnings ratio-5.98
Dividend yield
Dividend yield
Average volume
842.81K
Average volume842.81K
High today
$20.20
High today$20.20
Low today
$19.17
Low today$19.17
Open price
$19.73
Open price$19.73
Volume
686.64K
Volume686.64K
52 Week high
$21.71
52 Week high$21.71
52 Week low
$3.42
52 Week low$3.42

URGN News

TipRanks 3d
UroGen Pharma’s UGN-104 Study: A Potential Game-Changer in Urothelial Cancer Treatment

Urogen Pharma ((URGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Un...

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own URGN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.